Side-by-side comparison of AI visibility scores, market position, and capabilities
CMR Surgical makes the Versius robotic surgery system used in 30+ countries across 30,000+ procedures; raised $1.43B total; received FDA clearance in Oct 2024; raised $200M in Apr 2025; exploring ~$4B sale.
CMR Surgical is a Cambridge, UK-based medical robotics company that developed Versius, a modular, portable robotic surgery system designed to integrate into any standard operating room without requiring dedicated infrastructure. Founded in 2014, CMR Surgical built Versius to be smaller, lighter, and more flexible than established competitors, enabling surgeons to perform minimally invasive laparoscopic procedures — including cholecystectomy, hernia repair, and colorectal surgery — with robotic precision. Versius uses a wristed instrument design that mimics natural hand and wrist movements, providing surgeons enhanced dexterity within confined surgical spaces.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.